Study: Medicare spends millions on cancer treatments without clinical benefit
Medicare spent nearly $600 million over a three-year period for cancer care involving four Food and Drug Administration-approved drugs later found to provide no clinical benefit for certain forms of the disease.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health | Medicare | Study